33 results
S-8
EX-99.3
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
shall determine the effect on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other
8-K
EX-1.1
k0cci8h4u
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
s3q211udghg76uozdn
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
nn3rc faidu
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
EX-1.1
wdd5fg 6n90q0ah4
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
49ns25rbumh t57z
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
4ob7r1pzkyr35e0
20 Jul 22
Prospectus supplement for primary offering
4:22pm
DEF 14A
q7lkgd5b6z1500
29 Apr 22
Definitive proxy
7:01am
10-K
EX-10.4
e5xyegvlvllvy
14 Mar 22
Annual report
7:04am
10-K
EX-10.19
pm7qmneq433sc
14 Mar 22
Annual report
7:04am
424B4
b770in8tbi9 zum5l
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-10.19
dg7e b22sljen25273
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
EX-10.20
bk747h17lsh7j9l5
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
EX-10.5
talv 7ncdk
14 Jun 21
IPO registration (amended)
6:15am